Technology | January 19, 2010

New Suite of Tools Aids Cardiovascular Research

January 19, 2010 – A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro was launched today by iWorks. The systems, software and components are used for a number of research applications, including measuring and analyzing blood pressure, electrocardiograms, blood flow and cardiac output, pressure-volume, sonomicrometry dimension and volume, isolated Langendorff and working heart models and isolated tissue studies.

iWorx LabScribe2 recording and analysis software provides a comprehensive set of preconfigured routines to simplify data interpretation and analysis. Specific software modules for cardiovascular research are available to analyze pressure signals, blood flow data, ECG recordings, ventricular pressure-volume loops and sonomicrometry dimension data. The software can display up to 128 channels of data simultaneously at sampling rates as high as 100,000 samples/second.

iWorx cardiovascular research solutions include complete tissue baths systems, blood flow systems, and myograph systems. A wide range of transducers, amplifiers, signal conditioners, multi-channel data recorders and accessories can be used for in situ experiments, isolated heart preparations and isolated tissue protocols.

For more information: www.iworx.com.


Related Content

News | Cardiovascular Clinical Studies

April 22, 2024 β€” Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 β€” CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 β€” Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 β€” People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 β€” People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
Subscribe Now